Bimekizumab in Plaque Psoriasis

Clinical trial NCT06336343 · COMPLETED

Trial details

NCT number: NCT06336343
Sponsor: Icahn School of Medicine at Mount Sinai
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2024-06-03
Primary completion: 2026-03-17
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.